Andrés García‐Palomo
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors(2018)344 cited
- → Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells(2013)232 cited
- → Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial—PEARL(2020)131 cited
- → Modulation of Autophagy by Sorafenib: Effects on Treatment Response(2016)116 cited
- → Inhibition of matrix metalloproteinase‐9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells(2013)101 cited
- → Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: role of the MT1 receptor(2011)87 cited
- → Melatonin Activates Endoplasmic Reticulum Stress and Apoptosis in Rats with Diethylnitrosamine-Induced Hepatocarcinogenesis(2015)84 cited
- → FoxO Proteins: Regulation and Molecular Targets in Liver Cancer(2014)75 cited
- → Melatonin enhances sorafenib actions in human hepatocarcinoma cells by inhibiting mTORC1/p70S6K/HIF-1α and hypoxia-mediated mitophagy(2017)73 cited
- → Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells(2019)51 cited